|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
2590
|
(S)-1-(2-Amino-3-nitrophenoxy)-3-tert-butylamino-propan-2-ol
|
2590.0005: 5 mg per vial
2590.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [11C]CGP 12177
|
|
|
|
|
|
|
|
|
Molar Mass: 283.32
|
|
|
C13H21N3O4
|
|
|
[132059-12-2]
|
|
|
|
|
|
Yellowish solid packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H and 13C NMR spectra
|
|
|
Chemical Name:
CA index name: 2-Propanol, 1-(2-amino-3-nitrophenoxy)-3-[(1,1-dimethylethyl)amino]-, (S)-
|
|
|
Synonymes:
(S)-1-(2-Amino-3-nitrophenoxy)-3-tert-butylamino-propan-2-ol
|
|
|
Literature:
1. Hammadi A. et al. Asymmetric synthesis of (2S)-and (2R)-4-(3-tert-butylamino-2-hydroxypropoxy)benzimidazol-2-[11C]-one ((S)-and (R)-[11C]-CGP 12177) from optically active precursors J. Labelled Compd. Radiopharm. 1991, 29, 681-90
|
|
|
2. Merlet P. et al. Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993, 87, 1169-1178.
|
|
|
3. Nishijima K. et al. Preparation and pharmaceutical evaluation for clinical application of high specific activity S-(-)-[11C]CGP-12177, a radioligand for [beta]-adrenoreceptors. Nucl. Med. Commun. 2004, 25, 845-849.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|